Pulmonary vasodilator response to vagal stimulation is blocked by N omega-nitro-L-arginine methyl ester in the cat.

The effect of N omega-nitro-L-arginine methyl ester (L-NAME), an inhibitor of endothelium-derived relaxing factor production, on the vasodilator response to efferent vagal stimulation was investigated in the pulmonary vascular bed of the intact-chest cat under conditions of controlled blood flow and constant left atrial pressure. When pulmonary vascular tone was increased with U46619, efferent vagal stimulation decreased lobar arterial pressure in a stimulus-frequency-dependent manner. The decreases in lobar arterial pressure were enhanced by pretreatment with reserpine, were blocked by atropine, and were not altered by propranolol, indicating that the neurogenic vasodilator response was cholinergic in nature. The decreases in lobar arterial pressure in response to vagal stimulation and to exogenously administered acetylcholine were reduced after administration of L-NAME (100 mg/kg i.v.). Although L-NAME decreased pulmonary vasodilator responses to vagal stimulation and to acetylcholine, responses to adenosine, nicorandil, lemakalim, isoproterenol, prostaglandin E1, sodium nitroprusside, and 8-bromo-cGMP, agents that act by a variety of mechanisms, were not decreased. These results are consistent with the hypothesis that efferent vagal stimulation releases acetylcholine, which dilates the pulmonary vascular bed by stimulating the production of nitric oxide or a labile nitroso compound from L-arginine.

[1]  T. McMahon,et al.  N omega-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. , 1991, Journal of applied physiology.

[2]  M. Heymann,et al.  N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. , 1991, The American journal of physiology.

[3]  S. Moncada,et al.  Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Kadowitz,et al.  N omega-nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. , 1991, The American journal of physiology.

[5]  D. Rodman,et al.  Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. , 1991, The American journal of physiology.

[6]  S. Abman,et al.  Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. , 1990, The American journal of physiology.

[7]  S. Moncada,et al.  Modulatory role of endogenous nitric oxide in pulmonary circulation in vivo. , 1990, European journal of pharmacology.

[8]  N. Toda,et al.  Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle. , 1990, Biochemical and biophysical research communications.

[9]  G. Boeckxstaens,et al.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter , 1990, Nature.

[10]  F. Murad,et al.  Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation , 1990 .

[11]  A. Gibson,et al.  l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.

[12]  J. López-Belmonte,et al.  Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation , 1989, British journal of pharmacology.

[13]  P. Kadowitz,et al.  Analysis of responses to sympathetic nerve stimulation in the feline pulmonary vascular bed. , 1989, Journal of applied physiology.

[14]  L. Ignarro,et al.  L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. , 1989, Biochemical and biophysical research communications.

[15]  O. Griffith,et al.  NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? , 1989, Biochemical and biophysical research communications.

[16]  S. Moncada,et al.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[17]  P. Kadowitz,et al.  Pulmonary Vasodilator Responses to Vagal Stimulation and Acetylcholine in the Cat , 1983, Circulation research.

[18]  S. Holzmann Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG‐75) , 1983, Journal of cardiovascular pharmacology.

[19]  R. Hibbs,et al.  A light and electron microscopic study of the innervation of pulmonary arteries in the cat , 1981, The Anatomical record.

[20]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[21]  C. Hebb,et al.  Pulmonary vasomotor fibres in the cervical vagosympathetic nerve of the dog. , 1952, Quarterly journal of experimental physiology and cognate medical sciences.

[22]  T. Evans,et al.  Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. , 1991, The American review of respiratory disease.

[23]  R. Reich,et al.  Stimulation of coronary guanylate cyclase by nicorandil (SG-75) as a mechanism of its vasodilating action. , 1985, Journal of cyclic nucleotide and protein phosphorylation research.